Evidence of thalamic gray matter loss in pediatric multiple sclerosis

Neurology

Volumn 70, Issue 13 PART 2, 2008, Pages 1107-1112

  Mesaros, S ^a   Rocca, M A ^a   Absinta, M ^a   Ghezzi, A ^b   Milani, N ^c   Moiola, L ^a   Veggiotti, P ^d   Comi, G ^a   Filippi, Massimo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b Ospedale di Gallarate   (Italy)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

^d C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE DURATION; FEMALE; GRAY MATTER; HUMAN; MALE; MULTIPLE SCLEROSIS; NERVE DEGENERATION; PARAMETRIC TEST; PRIORITY JOURNAL; SCHOOL CHILD; THALAMUS;

EID: 41549163323     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000291010.54692.85     Document Type: Article

References (41)

1. Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain 1999;122:17-26.
2. Peterson JW, Bö L, Mörk S, Chang A, Trapp BD. Transected neuritis, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001;50:389-400.
3. Ceccarelli A, Rocca MA, Falini A, et al. Normal-appearing white and gray matter damage in MS. A volumetric and diffusion tensor MRI study at 3.0 Tesla. J Neurol 2007;254:513-518.
4. Chard DT, Griffin CM, McLean MA, et al. Brain metabolite changes in cortical gray and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain 2002;125:2342-2352.
5. Rovaris M, Bozzali M, Iannucci G, et al. Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance study. Arch Neurol 2002;59:1406-1412.
6. Valsasina P, Benedetti B, Rovaris M, Sormani MP, Comi G, Filippi M. Evidence for progressive gray matter loss in patients with relapsing-remitting multiple sclerosis. Neurology 2005;65:1126-1128.
7. Oreja-Gueavara C, Rovaris M, Iannucci G, et al. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis. A longitudinal diffusion tensor magnetic resonance imaging study. Arch Neurol 2005;62:578-584.
8. Chard DT, Griffin CM, Rashid W, et al. Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis. Mult Scler 2004;10:387-391.
9. De Stefano N, Matthews PM, Filippi M, et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003;60:1157-1162.
10. Dalton CM, Chard DT, Davies GR, et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004;127:1101-1107.
11. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage 2001;14:21-36.
12. Audoin B, Davies GR, Finisku L, Chard DT, Thompson AJ, Miller DH. Localization of grey matter atrophy in early RRMS: A longitudinal study. J Neurol 2006;253:1495-1501.
13. Prinster A, Quarantelli M, Orefice G, et al. Gray matter loss in relapsing-remitting multiple sclerosis: a voxel based morphometry study. NeuroImage 2006;29:859-867.
14. Sepulcre J, Sestre-Garriga J, Cercignani M, Ingle GT, Miller DH, Thomspon AJ. Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study. Arch Neurol 2006;63:1175-1180.
15. Morgen K, Sammer G, Courtney SM, et al. Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS. NeuroImage 2006;15:891-898.
16. Mezzapesa DM, Rocca MA, Falini A, et al. A preliminary diffusion tensor and magnetization transfer magnetic resonance imaging study of early-onset multiple sclerosis. Arch Neurol 2004;61:366-368.
17. Tortorella P, Rocca MA, Mazzapesa D, et al. MRI quantification of gray and white matter damage in patients with early-onset multiple sclerosis. J Neurol 2006;253:903-907.
18. Simone IL, Carrara D, Tortorella C, et al. Course and prognosis in early-onset MS: comparison with adult-onset forms. Neurology 2002;59:1922-1928.
19. Confavreux C, Vukusic A, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003;126:770-782.
20. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1442-1452.
21. Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 1991;54:683-688.
22. Rovaris M, Filippi M, Calori G, et al. Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol 1997;244:266-270.
23. Smith SM, De Stefano N, Jenkinson M, Matthews PM. Normalized accurate measurement of longitudinal brain change. J Comput Assist Tomogr 2001;25:466-475.
24. Ashburner J, Friston KJ. Voxel-based morphometry-the methods. NeuroImage 2000;11:805-821.
25. Balassy C, Bernert G, Wober-Bingol C, et al. Long-term MRI observations of childhood-onset relapsing-remitting multiple sclerosis. Neuropediatrics 2001;32:28-37.
26. Brownell B, Hughes J. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962;25:315-320.
27. Cifeli A, Arridge M, Jezzard P, Esiri MM, Palace J, Matthews PM. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002;52:650-653.
28. Ormerod IE, Miller DH, McDonald WI, et al. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain 1987;110:1579-1616.
29. Wylezinska M, Cifelli A, Jezzard P, Palace J, Alecci M, Matthews PM. Thalamic neurodegeneration in relapsing-remitting multiple sclerosis. Neurology 2003;60:1949-1954.
30. Fabiano AJ, Sharma J, Weinstock-Guttman B, et al. Thalamic involvement in multiple sclerosis: a diffusion-weighted magnetic resonance imaging study. J Neuroimaging 2003;13:307-314.
31. Inglese M, Park SJ, Johnson G, et al. Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3T. Arch Neurol 2007;64:196-202.
32. Inglese M, Liu S, Babb JS, Mannon LJ, Grossman RI, Gonen O. Three-dimensional proton spectroscopy of deep gray matter nuclei in relapsing-remitting MS. Neurology 2004;63:170-172.
33. Geurts JJ, Reuling IEW, Vrenken H, et al. MR spectroscopy evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis. Magn Reson Med 2006;55:478-483.
34. Ciccarelli O, Werring DJ, Wheeler-Kingshott CA, et al. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 2001;56:926-933.
35. Niepel G, Tench CR, Morgan PS, Evangelou N, Auer DP, Constantinescu CS. Deep gray matter and fatigue in MS. A T1 relaxation time study. J Neurol 2006;253:896-902.
36. Audion B, Ranjeva J-P, Duong MVA, et al. Voxel-based analysis of MTR images : a method to locate gray matter abnormalities in patients at earliest stage of multiple sclerosis. J Magn Reson Imaging 2004;20:765-771.
37. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121-127.
38. Alexander G, Crutcher M. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990;13:166-171.
39. Filippi M, Rocca M, Colombo B, et al. Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. NeuroImage 2002;15:559-567.
40. Mikaeloff Y, Adamsbaum C, Husson B, et al. MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain 2004;127:1942-1947.
41. Dale RC, de Sousa C, Chong WK, Cox TC, Harding B, Neville BG. Acute disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000;123:2407-2422.